Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0027819 (
neuroblastoma
)
27,800
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
We have isolated a human and murine homologue of the Drosophila prune gene through dbEST searches. The gene is ubiquitously expressed in human adult tissues, while in mouse developing embryos a high level of expression is confined to the nervous system particularly in the dorsal root ganglia, cranial nerves, and neural retina. The gene is composed of eight exons and is located in the 1q21.3 chromosomal region. A pseudogene has been sequenced and mapped to chromosomal region 13q12. PRUNE protein retains the four characteristic domains of DHH phosphoesterases. The synergism between prune and awdK-pn in Drosophila has led various authors to propose an interaction between these genes. However, such an interaction has never been supported by biochemical data. By using interaction-mating and in vitro co-immunoprecipitation experiments, we show for the first time the ability of human
PRUNE
to interact with the human homologue of awd protein (nm23-H1). In contrast,
PRUNE
is impaired in its interaction with nm-23-H1-S120G mutant, a gain-of-function mutation associated with advanced
neuroblastoma
stages. Consistently,
PRUNE
and nm23-H1 proteins partially colocalize in the cytoplasm. The data presented are consistent with the view that
PRUNE
acts as a negative regulator of the nm23-H1 protein. We discuss how
PRUNE
regulates nm23-H1 protein and postulate possible implications of
PRUNE
in
neuroblastoma
progression.
...
PMID:Evidence for interaction between human PRUNE and nm23-H1 NDPKinase. 1060 78
PRUNE
, the human homologue of the Drosophila gene, is located in 1q21.3, a region highly amplified in human sarcomas, malignant tumours of mesenchymal origin. Prune protein interacts with the metastasis suppressor nm23-H1, but shows impaired affinity towards the nm23-H1 S120G mutant associated with advanced
neuroblastoma
. Based on these observations, we previously suggested that prune may act as a negative regulator of nm23-H1 activity. We found amplification of
PRUNE
in aggressive sarcoma subtypes, such as leiomyosarcomas and malignant fibrous histiocytomas (MFH) as well as in the less malignant liposarcomas.
PRUNE
amplification was generally accompanied by high mRNA and moderate to high protein levels. The sarcoma samples expressed nm23-H1 mostly at low or moderate levels, whereas mRNA and protein levels were moderate to high in breast carcinomas. For the more aggressive sarcoma subtypes, 9/13 patients with
PRUNE
amplification developed metastases. A similar situation was observed in all breast carcinomas with amplification of
PRUNE
. Infection of NIH3T3 cells with a
PRUNE
recombinant retrovirus increased cell proliferation. Possibly, amplification and overexpression of
PRUNE
has the same effect in the tumours. We suggest that amplification and overexpression of
PRUNE
could be a mechanism for inhibition of nm23-H1 activity that affect the development or progression of these tumours.
...
PMID:Amplification and overexpression of PRUNE in human sarcomas and breast carcinomas-a possible mechanism for altering the nm23-H1 activity. 1168 67